Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

MYRIAD GENETICS INC (MYGN) Class Action Lawsuit (April 2018)

Closed

2:18cv00336 • April 20, 2018

Class Period Start

May 7, 2014

Class Period End

March 12, 2018

PSLRA Deadline

June 19, 2018

Case Allegations

10b5

Statutes of Repose

May 7, 2017

Country

United States

Court

Federal Court

Docket History

Apr 24, 2019

No Appeal- Closed

Mar 25, 2019

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Oct 30, 2018

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jun 19, 2018

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Apr 20, 2018

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in MYRIAD GENETICS INC.

TOP